Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Price
Target price
€242.25

€242.25

-0.100%
-0.25
-0.100%
€308.19
 
15:53 / Tradegate WKN: 867900 / Symbol: AMGN / Name: Amgen / Stock / Biotechnology & Medical Research / Large Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction

Amgen Inc. Stock

The stock is one of the favorites of our community with 24 Buy predictions and 4 Sell predictions.
With a target price of 308 € there is a positive potential of 27.14% for Amgen Inc. compared to the current price of 242.25 €.
So far the community has only identified positive things for Amgen Inc. stock. The most positive votes were given for criterium "Balance Sheet Risk".

Pros and Cons of Amgen Inc. in the next few years

Pros
?
S********** s********
?
G***** c******* t* c**********
?
C******** o* t** e**********
Cons
?
W********* I********* f** t** n*** y****
?
M***** P*******
?
B****
Tell us your opinion to access the 'Wisdom of the Crowds'

Performance of Amgen Inc. vs. its peers

Security Change(%) 1w 1m 1y YTD 3y 5y
Amgen Inc. -0.100% 3.921% -3.213% -19.755% -3.213% 4.797% 14.711%
Regeneron Pharmaceuticals Inc. -3.660% 3.739% 0.438% -50.756% -25.340% -27.806% 3.526%
Exact Sciences 1.050% -0.077% 12.034% -27.742% -16.541% 30.024% -27.081%
Incyte Corp. 0.950% 1.670% -1.020% 21.935% 9.282% 4.847% -3.168%

sharewise BeanCounterBot

The analysis provided is generated by an artificial intelligence system and is provided for informational purposes only. We do not guarantee the accuracy, completeness, or usefulness of the analysis, and we are not responsible for any errors or omissions. Use of the analysis is at your own risk.
Last updated at 2023-11-14

Die Geldeinnahmen von Amgen (US-Symbol AMGN) deuten auf eine starke Leistung hin, die sich in entscheidenden Finanzmetriken wie Umsatz, Betriebskapital und Rentabilität widerspiegelt. Die Bilanzen des Unternehmens über die Jahre zeigen eine beständige Vermögensbasis und anhaltende Rentabilität. Die Analyse der Cashflow-Berichte zeigt, dass das Unternehmen robuste Betriebscashflows generiert, was auf solide betriebliche Leistung und Liquiditätsmanagement hindeutet.

Gehen wir tiefer in die einzelnen Vorteile und Nachteile der Finanzen von Amgen ein.

Die umfangreichen Vermögenswerte von Amgen, wie in den Jahresbilanzen gezeigt, beinhalten sowohl kurzfristige Vermögenswerte, die eine starke Liquidität signalisieren, als auch längerfristige Vermögenswerte, die eine solide Investition in den Forschungs- und Entwicklungsbereich verdeutlichen.

Comments

Prediction Buy
Perf. (%) -1.84%
Target price 292.410
Change
Ends at 25.08.26

Amgen (NASDAQ:AMGN) had its price target raised by analysts at Piper Sandler from $328.00 to $342.00. They now have an "overweight" rating on the stock.
Ratings data for AMGN provided by MarketBeat
Show more

Prediction Sell
Perf. (%) -6.54%
Target price 222.320
Change
Ends at 23.07.26

Amgen Inc. (NASDAQ: AMGN) had its price target raised by analysts at Bank of America Corporation from $252.00 to $261.00. They now have an "underperform" rating on the stock.
Ratings data for AMGN provided by MarketBeat
Show more

Prediction Buy
Perf. (%) 2.70%
Target price 280.342
Change
Ends at 27.06.26

Amgen Inc. (NASDAQ: AMGN) had its "overweight" rating re-affirmed by analysts at Piper Sandler. They now have a $328.00 price target on the stock.
Ratings data for AMGN provided by MarketBeat
Show more

News

Here Is My Top Stock Pick Among the Weight Loss Industry Leaders: https://g.foolcdn.com/editorial/images/832010/investors-look-at-tablet-outside.jpg
Here Is My Top Stock Pick Among the Weight Loss Industry Leaders

The new generation of effective weight loss drugs has generated billions of dollars for industry leaders Eli Lilly (NYSE: LLY) and Novo Nordisk (NYSE: NVO), and opened the door for companies such as

2 Healthcare Dividend Stocks to Buy and Hold: https://g.foolcdn.com/editorial/images/832604/doctor-and-patient-talking.jpg
2 Healthcare Dividend Stocks to Buy and Hold

Between labor-market data and potential interest-rate cuts, Wall Street has a lot on its plate right now. In an environment like this one, it can be helpful to invest in solid, dividend-paying

If You'd Invested $10,000 in Amgen Stock (AMGN) 3 Years Ago, Here's How Much You'd Have Today: https://g.foolcdn.com/editorial/images/830030/getty-decisions-choices-multiple-directions-thinking-opportunity.jpg
If You'd Invested $10,000 in Amgen Stock (AMGN) 3 Years Ago, Here's How Much You'd Have Today

Quick -- what were you doing back in September of 2022? Were you buying $10,000 of stock in Amgen (NASDAQ: AMGN)? If so, you might be wondering what that's worth today. Even if you didn't buy Amgen